Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Bure Equity AB ( (SE:BURE) ) is now available.
Bure Equity AB reported a difficult 2025, with net asset value per share falling 19.8% to SEK 267.2 and group earnings after tax swinging to a loss of SEK 4.7 billion, sharply underperforming the broader Swedish market. Weak share price performance in several key portfolio companies, notably Yubico, Xvivo and Vitrolife, offset strong results from Mycronic, while management intensified portfolio rebalancing through divestments in Ovzon and Mentice and a major SEK 900 million investment in MEMS foundry leader Silex Microsystems, signalling a continued long-term commitment to technology assets despite a challenging market and early 2026 NAV declines.
The CEO highlighted that Bure’s concentration in growth technology stocks, combined with a stronger Swedish krona and missed growth expectations in some holdings, drove severe valuation compressions and a negative total shareholder return of 34.8%. At the same time, the group emphasized operational improvements in select unlisted assets such as Mentimeter, strategic shifts in geographic exposure like Vitrolife’s gains in North America, and a belief that enhancing profitability across portfolio companies is key to restoring growth and supporting stakeholders amid ongoing macroeconomic and geopolitical uncertainty.
The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK215.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.
More about Bure Equity AB
Bure Equity AB is a Swedish investment company focused on export-oriented, fast-growing technology and healthcare businesses, including holdings in firms such as Yubico, Xvivo, Vitrolife and Mycronic. Through both listed and unlisted investments, Bure targets companies with strong growth potential, particularly in advanced industrial, medtech, and semiconductor-related niches.
Average Trading Volume: 97,629
Technical Sentiment Signal: Sell
Current Market Cap: SEK14.3B
For detailed information about BURE stock, go to TipRanks’ Stock Analysis page.